Trademark Overview
On Friday, November 8, 2024, a trademark application was filed for RHYGAZE with the United States Patent and Trademark Office. The USPTO has given the RHYGAZE trademark a serial number of 79413712. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 2, 2025. This trademark is owned by RhyGaze AG. The RHYGAZE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical and medical preparations and products, biological medical and pharmaceutical preparations and products; pharmaceutical and biological preparations for medical use, namely nucleic acids, proteins, protein conjugates, peptides, attenuated viruses, viral vectors and vector constructions; biological tissue cultures for medical use; biological tissue cultures intended for use in the diagnosis, prevention and treatment of diseases, in particular eye diseases; biological tissue cultures intended for use in gene therapy treatments.
Medical services; medical services, namely medical diagnosis through molecular biology, genetic engineering and biotechnology methods, in particular in the field of eye diseases; therapy services, in particular gene therapy.
Scientific and technological services as well as research and design services relating thereto; quality control and authentication services; design and development of computers and software; research and development services in the fields of molecular biology, biotechnology, pharmacy and medicine; research and development services in the fields of molecular biology, biotechnology, pharmacy and medicine, in particular in the field of eye diseases; research and development services in the field of medical diagnostics, prophylaxis and therapy, in particular gene therapy; research services, namely examination and research of compounds and components intended for therapeutic or diagnostic use, in particular intended for use in relation to eye diseases; research services in the field of gene therapy; developing protocols, technical planning, advice and services in the fields of molecular biology, biotechnology and pharmacy, in particular intended for use in the field of ocular diseases and g...
